Non-opioid Pain Patches Market

Non-opioid Pain Patches Market contains market size and forecasts of Non-opioid Pain Patches in global, including the following market information:

• Global Non-opioid Pain Patches Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Non-opioid Pain Patches Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Non-opioid Pain Patches companies in 2021 (%)

The global Non-opioid Pain Patches market was valued at 649.7 million in 2021 and is projected to reach US$ 771.6 million by 2028, at a CAGR of 2.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lidocaine Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-opioid Pain Patches include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical and Teikoku Seiyaku, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Non-opioid Pain Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-opioid Pain Patches Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Non-opioid Pain Patches Market Segment Percentages, by Type, 2021 (%)

• Lidocaine Patch
• Diclofenac Patch
• Methyl Salicylate Patch
• Capsaicin Patch
• Ketoprofen Patch
• Others

Global Non-opioid Pain Patches Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Non-opioid Pain Patches Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Independent Pharmacies & Drug Stores
• Online Pharmacies

Global Non-opioid Pain Patches Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Non-opioid Pain Patches Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Non-opioid Pain Patches revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Non-opioid Pain Patches revenues share in global market, 2021 (%)
• Key companies Non-opioid Pain Patches sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Non-opioid Pain Patches sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• GlaxoSmithKline
• Johnson & Johnson
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries
• Hisamitsu Pharmaceutical
• TEH SENG Pharmaceutical
• Teikoku Seiyaku
• IBSA Institut Biochimque SA
• Acorda Therapeutics
• Allergan PLC
• Endo International